Aurobindo concludes acquisition of Actavis Illustrative image – not actual.

Aurobindo Pharma has completed acquisition of certain commercial operations of Actavis, a Dublin-based pharmaceutical company, in Western Europe.


The agreement to buy Actavis' operations was announced in January 2014. Actavis and Aurobindo have also entered into a long term commercial and supply arrangement.


Following receipt of clearances from the competent authorities, Aurobindo aims to combine the strength of both the companies in these markets.


The acquisition expands Aurobindo's front-end operations into five segments -- generics; prescription products; over-the-counter products; hospital products; and generic tenders, with approximately 1,200 products and an additional pipeline of over 200 products.


The company has acquired personnel, commercial infrastructure, products, marketing authorisations, and dossier licence rights, in seven European countries.


 

← All latest storiesBack to top →